Novo Nordisk changes strategy in Germany, launches diabetes drug

COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk, the world's biggest insulin producer, said on Wednesday it had decided to launch its diabetes drug Tresiba in Germany on May 1 after seeing signs of a more favourable pricing situation there.

via Reuters: Health News Read More Here..